Immediate Impact

1 by Nobel laureates 50 standout
Sub-graph 1 of 25

Citing Papers

mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
5 intermediate papers

Works of Steve Kwilas being referenced

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
2016
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
2014

Author Peers

Author Last Decade Papers Cites
Steve Kwilas 214 26 53 45 7 273
Megan C. Mears 241 30 48 99 10 334
Christopher W. Schellhase 184 20 53 27 8 250
Nazly Shafagati 171 19 50 130 13 331
D. Hannaman 131 35 78 96 10 335
M. A. Donets 75 32 149 56 10 303
Regina K. Rowe 86 9 100 56 11 290
Olaf Niederstraßer 137 31 159 37 6 285
Andreas Schoen 227 47 56 55 13 310
Lorellin A. Durnell 118 7 46 67 8 319
Justine M. Zelko 229 23 66 45 8 289

All Works

Loading papers...

Rankless by CCL
2026